A phase I trial of humanized monoclonal antibody HuM195 (anti-CD33) with low-dose interleukin 2 in acute myelogenous leukemia. (Q40630916)
Jump to navigation
Jump to search
scientific article published on October 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I trial of humanized monoclonal antibody HuM195 (anti-CD33) with low-dose interleukin 2 in acute myelogenous leukemia. |
scientific article published on October 1999 |
Statements
A phase I trial of humanized monoclonal antibody HuM195 (anti-CD33) with low-dose interleukin 2 in acute myelogenous leukemia (English)
S E Kossman
D A Scheinberg
J G Jurcic
J Jimenez